Category: Parry
-
Speakeasy (EASY.C) completes $2m loan with interest rate just 5% shy of what’s considered loan sharking
I break laws sometimes. I speed on the highway. I possess more than the 30 gram legal limit of weed products. I sneak food into the cinema, or used to when the cinema was a thing we did in polite society. I’ve been drunk and disorderly, broken noise bylaws on a Saturday night, and I…
-
Ravenquest (RQB.V) CEO George Robinson resigns, company alleges he’s holding records hostage
For a company that once upon a time figured a great business model in the cannabis sector would be to tattle on other license holders in an effort to be installed as replacement licensees, Ravenquest (RQB.V) sure was terrible at handling it’s own business when it got right down to it. The company lost access…
-
The case that Supreme Cannabis (FIRE.T) is about to shake its demons and go on a rip
Supreme Cannabis (FIRE.T) got a new President and CEO today in Beena Goldenberg, former chief executive officer of Hain-Celestial Canada, and a bona fide pro in the natural and plant-based consumer packaged goods business. This would appear to be a good hire for a company that already has a great reputation for quality products in…
-
Nexus Gold (NXS.V) – finally – actually – miraculously – lifts on news, up 50%
At Equity.Guru, we’ve been tight with Nexus Gold (NXS.V) boss Alex Klenman for years. he’s been through it with Nexus, from former CEOs selling off his stock in secret, filing their insde trading docs a year late, to stock promoters demanding money and then, upon being refused, crashing the stock, to dark pool shenanigans and…
-
Revive Therapeutics (RVV.C): Kicked around, called a fraud, gets FDA approval of Phase 3 COVID-19 trials
“Let them say what they want, we know what we’re doing, and we’re doing the work,” Michael Frank told me a month ago, as he put out news claiming his little pharma company, which had built a reputation for chasing aggressively into new pharmaceutical fields, had found some IP that might be useful in the…
-
Falcon Gold (FG.V), up 60% on new properties, drills turning, and the novel tactic of ‘doing work’
Karim Rayani is a deal guy from way back, a non-stop money raiser, deal maker, handshaker and groover/shaker. If you needed a guy to invest in a biotech deal, Karim would go find him. If you needed some dough to kickstart a palladium mine, Karim will have a guy who knows a guy. And if…
-
Canopy Growth Corp (WEED.T) to detonate another $800m in assets in bid to find balance sheet harmony
There’s no doubt a lot of people invest in a sector by just plopping their dough behind whichever company is the biggest, or the one they’ve heard of most, without actually looking at the fundamentals of that company. This is as much a cemented belief for me as the belief that songs that get played…
-
European office supplies manufacturer takes Wayland Group (WAYL.C) weed grow for $12.3m
The Wayland Group (WAYL.C) announced Thursday Austria-based Ring Holding International AG will purchase their Maricann assets, which essentially make up their entire business, for the bargain price of $12.3 million as part of ongoing bankruptcy proceedings. The purchaser of the Maricann assets is a family office with a core focus on the manufacturing of lever…
-
Revive Therapeutics (RVV.C) warned about overhype, but up 26% on clinical trial news
Oddball pharmaceutical player Revive Therapeutics (RVV.C) found itself on the back end of a warning by the BCSC this week, that certain German players in the smallcap promotion space had over-hyped the mushroom/cannabis/biotech deal and promised big wins inappropriately for anyone who invested. As a marketing partner of Revive, I got a few panicky texts…
-
Cannabis beverages are here at last: So where the hell are they?
When the cannabis edibles space first became a potentially legal thing in Canada, my first thought was about how my life would change for the better when I could drink a beverage that would either hit me with a nice shot of CBD, or wipe me out with THC, or hey – maybe both. Fast…